New Tooth-Saving material could spare kids from extractions

NCT ID NCT07702942

First seen Jul 14, 2026 · Last updated Jul 16, 2026 · Updated 2 times

Summary

This study tests whether a newer, easier-to-use material called NeoPUTTY works as well as the standard MTA for saving permanent back teeth with severe nerve inflammation in children aged 9 to 14. Both materials are used to cover the remaining healthy nerve after removing the diseased part, aiming to keep the tooth alive and avoid extraction. Forty-six children were randomly assigned to receive one of the two materials and were followed for a year to check for pain, infection, and healing.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
NeoPUTTY (a premixed calcium silicate bioceramic material) and Mineral Trioxide Aggregate (MTA) used as pulp-capping materials after pulpotomy
What this could lead to
If NeoPUTTY works as well as MTA, it could offer a simpler, faster option for saving severely inflamed teeth in children, reducing the need for extractions.
What could go wrong
This is a small study with only 46 children, and results may not apply to all ages or tooth types. The long-term success of NeoPUTTY is still unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IRREVERSIBLE PULPITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Post Graduate Institute of Dental Sciences, Rohtak

    Rohtak, Haryana, 124001, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.